These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Chirality and its importance in drug development. Campbell DB; Wilson K Biochem Soc Trans; 1991 Apr; 19(2):472-5. PubMed ID: 1889635 [No Abstract] [Full Text] [Related]
8. Present attitudes of governmental drug regulatory agencies. Noel PR Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283 [No Abstract] [Full Text] [Related]
9. FDA, states discuss pharmacy compounding regulatory framework. Traynor K Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976 [No Abstract] [Full Text] [Related]
10. Availability of medicines. Swarbrick O Vet Rec; 1992 May; 130(19):431. PubMed ID: 1307856 [No Abstract] [Full Text] [Related]
11. Availability of medicines. Armour J Vet Rec; 1992 Jun; 130(23):519. PubMed ID: 1641971 [No Abstract] [Full Text] [Related]
12. Legislation on medicines. Dunlop D Br Med J; 1970 Sep; 3(5725):760-2. PubMed ID: 5472762 [No Abstract] [Full Text] [Related]
13. Is the Hospital Authority's drug formulary equitable and efficient? Lau EW; Leung GM Hong Kong Med J; 2008 Oct; 14(5):416-7. PubMed ID: 18840919 [No Abstract] [Full Text] [Related]
14. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Chen ML Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051 [TBL] [Abstract][Full Text] [Related]
15. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
16. Availability of medicines. Rutter JM Vet Rec; 1992 May; 130(21):478. PubMed ID: 1626359 [No Abstract] [Full Text] [Related]